Provider
The smartphone-enabled LooK SPOT test scans for nucleocapsid protein from SARS-CoV-2 in nasal swabs, with results reportedly available in five to eight minutes.
The University Health Network study is being conducted in collaboration with the tech giant, and will enroll roughly 200 patients for three months of active monitoring with a two-year follow-up.
An article in NEJM reports that pulse oximeters missed occult hypoxemia in more Black patients than white.
Also: Cityblock Health adds former Livongo president to its board of directors; Virta Health's new CFO targets rapid growth.
With a single authentication, iPhone owners whose providers use DrChrono's OnPatient will be able to consolidate their records within Apple's PHR.
The Berlin-based platform aims to expand its suite of wellness services and coaching classes.
Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.
Despite the large number of commercially available sleep apps, a new systematic review calls for more evaluations to be conducted, and for more uniformity during the design process.
Volpara is purchasing all outstanding equity of CRA for $18 million and will pay an additional $4 million if certain strategic targets are met within 18 months.
The Kingdom’s BeAware app will be able to confirm an individual’s immunity status via a green shield and digital certificate that can be verified by officials at any given time.